Article Sidebar
Published:
Jun 22, 2005Article Details
How to Cite
Essilfie-Appiah, G., Hofmeyr, G., & Moodley, J. (2005). Misoprostol in obstetrics and gynaecology — benefits and risks. South African Journal of Obstetrics and Gynaecology, 11(1), 9–10. Retrieved from https://www.ajol.info/index.php/sajog/article/view/34286
Issue
Section
Articles
Material submitted for publication in the South African Journal of Obstetrics and Gynaecologyl (SAJOG) is accepted provided it has not been published elsewhere. Copyright forms will be sent with acknowledgement of receipt and the SAJOG reserves copyright of the material published.
The SAJOG does not hold itself responsible for statements made by the authors.
Main Article Content
Misoprostol in obstetrics and gynaecology — benefits and risks
Abstract
Misoprostol is currently being used for induction of labour at or near term and also for termination of pregnancy. Its use without proven dosage regimens is possibly associated with an increase in the incidence of uterine hyperstimulation, preterm labour, induced abortion above 20 weeks' gestation, meconium-stained liquor in the latent phase of labour, fetal distress and cases of uterine rupture as demonstrated by these case reports and literature review. Its use for these purposes must be under controlled circumstances, using minimum doses.
South African Journal of Obstetrics and Gynaecology Vol.11(1) 2005: 9-10
South African Journal of Obstetrics and Gynaecology Vol.11(1) 2005: 9-10
